University Clinical Hospital Mostar, Kralja Tvrtka b.b., 88000, Mostar, BA, Bosnia and Herzegovina; Faculty of Medicine, University of Mostar, Bijeli Brijeg b.b., 88000, Mostar, BA, Bosnia and Herzegovina.
Transfus Clin Biol. 2022 Aug;29(3):231-235. doi: 10.1016/j.tracli.2022.03.008. Epub 2022 Apr 26.
Currently, there are limited data on the prevalence of HBsAg in Bosnia and Herzegovina. This study aimed to evaluate the trend of HBsAg prevalence during a period of 20 years in relation to the implementation of pre-donation questionnaires based on parenteral and sexual risk factors and mandatory HBV vaccination.
This is a retrospective analysis performed on 67,336 blood donors at the University Clinical Hospital Mostar during three distinct periods: before introducing of mandatory HBV vaccination and pre-donation blood donor questionnaires (1998-2002); after introducing of pre-donation blood donor questionnaires, but without mandatory immunized blood donors (2004-2008); and after introducing of mandatory pre-donation blood donor questionnaires and mandatory vaccination (2015-2019).
According to implementation of mandatory pre-donation blood donor questionnaires and mandatory HBV vaccination the prevalence of HBsAg significantly decreased among blood donors in all three studied periods of time (0.303% in 1998-2002, 0.236% in 2004-2008, and 0.021% in 2015-2019; P<0.001). Out of 67,336 tested donors, there were 98 (0.145%) HBsAg-positive donors during analysed periods, with a mean age of 34.76±11.37 years. The mean age of HBsAg-positive donors was 30.72±10.40, 37.56±10.13, and 47.28±12.14) in the 1998-2002, 2004-2008, and 2015-2019 periods, respectively (P<0.001).
This study clearly shows a decreased rate of HBV infections among blood donors with respect to implementation of the HBV vaccination schedule and mandatory pre-donation blood donor questionnaires based on parenteral and sexual risk factors.
目前,波斯尼亚和黑塞哥维那(波黑)的 HBsAg 流行率数据有限。本研究旨在评估 20 年来与基于注射和性风险因素的预捐血问卷以及强制性乙型肝炎病毒(HBV)疫苗接种实施相关的 HBsAg 流行率趋势。
这是在莫斯塔尔大学临床医院的 67336 名献血者中进行的回顾性分析,分为三个不同时期:引入强制性 HBV 疫苗接种和预捐血献血者问卷之前(1998-2002 年);引入预捐血献血者问卷后,但没有强制性免疫献血者(2004-2008 年);以及引入强制性预捐血献血者问卷和强制性疫苗接种后(2015-2019 年)。
根据强制性预捐血献血者问卷和强制性 HBV 疫苗接种的实施情况,所有三个研究时间段的献血者中 HBsAg 的流行率均显著下降(1998-2002 年为 0.303%,2004-2008 年为 0.236%,2015-2019 年为 0.021%;P<0.001)。在 67336 名受检献血者中,分析期间有 98 名(0.145%)HBsAg 阳性献血者,平均年龄为 34.76±11.37 岁。HBsAg 阳性献血者的平均年龄分别为 30.72±10.40、37.56±10.13 和 47.28±12.14 岁,分别为 1998-2002 年、2004-2008 年和 2015-2019 年(P<0.001)。
本研究清楚地表明,随着 HBV 疫苗接种计划的实施以及基于注射和性风险因素的强制性预捐血献血者问卷的实施,献血者中 HBV 感染率有所下降。